{"title": "Protocols on safety, efficacy, standardization, and documentation of herbal medicine (IUPAC Technical Report)", "author": "M Mosihuzzaman; M Iqbal Choudhary", "url": "https://www.degruyter.com/document/doi/10.1351/pac200880102195/html", "hostname": "degruyter.com", "description": "This Technical Report compiles and analyzes the current scientific knowledge on herbal medicine and highlights the practical ways for ensuring the safety of herbal preparations and evaluating their claimed efficacy. Emphasis has been given to the methods for standardization of herbal medicine and the ways and means for moving forward to achieve the difficult goal of preparing herbal medicines of consistent quality and effects. Pragmatic approaches have been recommended to overcome the difficulties in (i) protecting intellectual property rights (IPR); (ii) producing safe, potent, standardized, and affordable herbal medicine; and (iii) documenting the knowledge base on herbal medicine in an easily accessible format.", "sitename": "De Gruyter", "date": "2008-01-01", "cleaned_text": "Abstract This Technical Report compiles and analyzes the current scientific knowledge on herbal medicine and highlights the practical ways for ensuring the safety of herbal preparations and evaluating their claimed efficacy. Emphasis has been given to the methods for standardization of herbal medicine and the ways and means for moving forward to achieve the difficult goal of preparing herbal medicines of consistent quality and effects. Pragmatic approaches have been recommended to overcome the difficulties in (i) protecting intellectual property rights (IPR); (ii) producing safe, potent, standardized, and affordable herbal medicine; and (iii) documenting the knowledge base on herbal medicine in an easily accessible format. [documentation](/search?query=keywordValues%3A%28%22documentation%22%29%20AND%20journalKey%3A%28%22PAC%22%29&documentVisibility=all&documentTypeFacet=article); [efficacy](/search?query=keywordValues%3A%28%22efficacy%22%29%20AND%20journalKey%3A%28%22PAC%22%29&documentVisibility=all&documentTypeFacet=article); [herbal Code: 2005-034-1-300 References 1. British Medical Association. Complementary Medicine New Approaches to Good Practice, Oxford University Press, Oxford (1993). [Search in Google Scholar](https://scholar.google.com/scholar?q=British%20Medical%20Association.%20Complementary%20Medicine%20New%20Approaches%20to%20Good%20Practice%2C%20Oxford%20University%20Press%2C%20Oxford%20%281993%29.) 2. R. C. Kessler, R. B. Davis, D. A. Foster, M. I. Van Rompay, E. E. Walters, S. A. Wilkey, T. J. Kaptchuk, D. M. Eisenberg. Ann. Intern. Med. 135, 262 (2001). [Search in Google Scholar](https://scholar.google.com/scholar?q=R.%20C.%20Kessler%2C%20R.%20B.%20Davis%2C%20D.%20A.%20Foster%2C%20M.%20I.%20Van%20Rompay%2C%20E.%20E.%20Walters%2C%20S.%20A.%20Wilkey%2C%20T.%20J.%20Kaptchuk%2C%20D.%20M.%20Eisenberg.%20Ann.%20Intern.%20Med.%20135%2C%20262%20%282001%29.) 3. [doi:10.1006/pmed.2002.1057](https://doi.org/doi:10.1006/pmed.2002.1057), A. H. MacLennan, D. H. Wilson, A. W. Taylor. Prev. Med. 35, 166 (2002). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1006%2Fpmed.2002.1057%20%2C%20A.%20H.%20MacLennan%2C%20D.%20H.%20Wilson%2C%20A.%20W.%20Taylor.%20Prev.%20Med.%2035%2C%20166%20%282002%29.) 4. [doi:10.1089/acm.1998.4.1-17](https://doi.org/doi:10.1089/acm.1998.4.1-17), C. M. Cassidy. J. Altern. Complement. Med. 4, 17 (1998). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1089%2Facm.1998.4.1-17%20%2C%20C.%20M.%20Cassidy.%20J.%20Altern.%20Complement.%20Med.%204%2C%2017%20%281998%29.) 5. A. Bensoussan, S. P. Myers. Towards a Safer Choice: The Practice of Traditional Chinese Medicine in Australia, Faculty of Health, University of Western Sydney, Macarthur (1996). [Search in Google Scholar](https://scholar.google.com/scholar?q=A.%20Bensoussan%2C%20S.%20P.%20Myers.%20Towards%20a%20Safer%20Choice%3A%20The%20Practice%20of%20Traditional%20Chinese%20Medicine%20in%20Australia%2C%20Faculty%20of%20Health%2C%20University%20of%20Western%20Sydney%2C%20Macarthur%20%281996%29.) 6. TDR 2005. Operational Guidance: Information Needed to Support Clinical Trials of Herbal Products, UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR) (2005). [Search in Google Scholar](https://scholar.google.com/scholar?q=TDR%202005.%20Operational%20Guidance%3A%20Information%20Needed%20to%20Support%20Clinical%20Trials%20of%20Herbal%20Products%2C%20UNICEF%2FUNDP%2FWorld%20Bank%2FWHO%20Special%20Program%20for%20Research%20and%20Training%20in%20Tropical%20Diseases%20%28TDR%29%20%282005%29.) 7. [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1067%2Fmcp.2001.120249%20%2C%20E.%20Ernst.%20Clin.%20Pharmacol.%20Ther.%2070%2C%20497%20%282001%29.) 8. [doi:10.1046/j.1365-2796.2002.00999.x](https://doi.org/doi:10.1046/j.1365-2796.2002.00999.x), E. Ernst. J. Intern. Med. 252, 107 (2002). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1046%2Fj.1365-2796.2002.00999.x%20%2C%20E.%20Ernst.%20J.%20Intern.%20Med.%20252%2C%20107%20%282002%29.) 9. [doi:10.1016/S0165-6147(00)01972-6](https://doi.org/doi:10.1016/S0165-6147(00)01972-6), E. Ernst. Trends Pharmacol. Sci. 23, 136 (2002). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2FS0165-6147%2800%2901972-6%20%2C%20E.%20Ernst.%20Trends%20Pharmacol.%20Sci.%2023%2C%20136%20%282002%29.) 10. P. A. G. M. De Smet, R. F. Chandler, P. P. H. But, K. Keller (Eds.). Adverse Effects of Herbal Drugs: Toxicological Outlook on the Quality Assurance of Herbal Medicines, pp. 1-72, Springer Verlag, Berlin (1992). [Search in Google Scholar](https://scholar.google.com/scholar?q=P.%20A.%20G.%20M.%20De%20Smet%2C%20R.%20F.%20Chandler%2C%20P.%20P.%20H.%20But%2C%20K.%20Keller%20%28Eds.%29.%20Adverse%20Effects%20of%20Herbal%20Drugs%3A%20Toxicological%20Outlook%20on%20the%20Quality%20Assurance%20of%20Herbal%20Medicines%2C%20pp.%201-72%2C%20Springer%20Verlag%2C%20Berlin%20%281992%29.) 11. \"Quality of herbal remedies\", in The Rules Governing Medicinal Products in the European Community, Office for Official Publications of the European Communities, Luxembourg, III, 31 (1989). [Search in Google Scholar](https://scholar.google.com/scholar?q=%22Quality%20of%20herbal%20remedies%22%2C%20in%20The%20Rules%20Governing%20Medicinal%20Products%20in%20the%20European%20Community%2C%20Office%20for%20Official%20Publications%20of%20the%20European%20Communities%2C%20Luxembourg%2C%20III%2C%2031%20%281989%29.) 12. [doi:10.1016/S0140-6736(05)80091-1](https://doi.org/doi:10.1016/S0140-6736(05)80091-1), T. Y. K. Chan, J. C. N. Chan, B. Tomlinson, J. A. J. H. Critchley. Lancet 342, 1532 (1993). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2FS0140-6736%2805%2980091-1%20%2C%20T.%20Y.%20K.%20Chan%2C%20J.%20C.%20N.%20Chan%2C%20B.%20Tomlinson%2C%20J.%20A.%20J.%20H.%20Critchley.%20Lancet%20342%2C%201532%20%281993%29.) 13. S. Brown, R. Ede. Br. J. Hosp. Med. 53, 469 (1996). [Search in Google Scholar](https://scholar.google.com/scholar?q=S.%20Brown%2C%20R.%20Ede.%20Br.%20J.%20Hosp.%20Med.%2053%2C%20469%20%281996%29.) 14. [doi:10.1001/jama.268.24.3430](https://doi.org/doi:10.1001/jama.268.24.3430), H. H. Schaumburg, A. Berger. J. Am. Med. Assoc. 268, 3430 (1992). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1001%2Fjama.268.24.3430%20%2C%20H.%20H.%20Schaumburg%2C%20A.%20Berger.%20J.%20Am.%20Med.%20Assoc.%20268%2C%203430%20%281992%29.) 15. O. Espinoza, M.-J. Mann, B. Bleasdell. N. Engl. J. Med. 333, 803 (1995). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1056%2FNEJM199509213331217%20%2C%20E.%20O.%20Espinoza%2C%20M.-J.%20Mann%2C%20B.%20Bleasdell.%20N.%20Engl.%20J.%20Med.%20333%2C%20803%20%281995%29.) 16. [doi:10.1056/NEJM199809173391214](https://doi.org/doi:10.1056/NEJM199809173391214), R. J. Ko. N. Engl. J. Med. 339, 847 (1998). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1056%2FNEJM199809173391214%20%2C%20R.%20J.%20Ko.%20N.%20Engl.%20J.%20Med.%20339%2C%20847%20%281998%29.) 17. G. M. Woolf, L. M. Petrovic, S. E. Rojter, S. Wainwright, F. G. Villamil, W. N. Katkov, P. Michieletti, I. R. Wanless, R. Stermitz, J. J. Beck, J. M. Vierling. Ann. Intern. Med. 121, 729 (1994). [Search in Google Scholar](https://scholar.google.com/scholar?q=G.%20M.%20Woolf%2C%20L.%20M.%20Petrovic%2C%20S.%20E.%20Rojter%2C%20S.%20Wainwright%2C%20F.%20G.%20Villamil%2C%20W.%20N.%20Katkov%2C%20P.%20Michieletti%2C%20I.%20R.%20Wanless%2C%20R.%20Stermitz%2C%20J.%20J.%20Beck%2C%20J.%20M.%20Vierling.%20Ann.%20Intern.%20Med.%20121%2C%20729%20%281994%29.) 18. [doi:10.1016/0140-6736(93)92984-2](https://doi.org/doi:10.1016/0140-6736(93)92984-2), Lancet 341, 387 (1993). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2F0140-6736%2893%2992984-2%20%2C%20J.-L.%20Vanherweghem%2C%20C.%20Tielemans%2C%20D.%20Abramowicz%2C%20M.%20Depierreux%2C%20R.%20Vanhaelen-Fastre%2C%20R.%20Vanhaelen%2C%20M.%20Vanhaelen%2C%20M.%20Drawta%2C%20C.%20Richard%2C%20D.%20Vendervelde%2C%20D.%20Verbeelen%2C%20M.%20Jadoul.%20Lancet%20341%2C%20387%20%281993%29.) 19. T. Y. K. Chan, J. A. J. H. Critchley. Hum. Exp. Toxicol. 15, 5 (1996). [Search in Google Scholar](https://scholar.google.com/scholar?q=T.%20Y.%20K.%20Chan%2C%20J.%20A.%20J.%20H.%20Critchley.%20Hum.%20Exp.%20Toxicol.%2015%2C%205%20%281996%29.) 20. T. J. Kaptchuk. Ann. Intern. Med. 122, 636 (1995). [10.7326/0003-4819-122-8-199504150-00032](https://doi.org/10.7326/0003-4819-122-8-199504150-00032) [Search in Google Scholar](https://scholar.google.com/scholar?q=T.%20J.%20Kaptchuk.%20Ann.%20Intern.%20Med.%20122%2C%20636%20%281995%29.) 21. [doi:10.1046/j.1440-1746.2001.02309.x](https://doi.org/doi:10.1046/j.1440-1746.2001.02309.x), G. J. Park, S. P. Mann, M. C. Ngu. J. Gastroenterol. Hepatol. 16, 115 (2001). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1046%2Fj.1440-1746.2001.02309.x%20%2C%20G.%20J.%20Park%2C%20S.%20P.%20Mann%2C%20M.%20C.%20Ngu.%20J.%20Gastroenterol.%20Hepatol.%2016%2C%20115%20%282001%29.) 22. [doi:10.1016/0140-6736(93)90404-5](https://doi.org/doi:10.1016/0140-6736(93)90404-5), P. P. But, D. J. Atherton, M. H. Rustin, J. Brostoff. Lancet 341, 637 (1993). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2F0140-6736%2893%2990404-5%20%2C%20P.%20P.%20But%2C%20D.%20J.%20Atherton%2C%20M.%20H.%20Rustin%2C%20J.%20Brostoff.%20Lancet%20341%2C%20637%20%281993%29.) M. Vanhaelen, R. Vanhaelen-Fastre, P. But, J.-L. Vanherweghem. Lancet 343, 174 (1994). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2FS0140-6736%2894%2990964-4%20%2C%20M.%20Vanhaelen%2C%20R.%20Vanhaelen-Fastre%2C%20P.%20But%2C%20J.-L.%20Vanherweghem.%20Lancet%20343%2C%20174%20%281994%29.) 24. M. Depierreux, B. Van Damme, K. V. Houte, J.-L. Vanherweghem. Am. J. Kidney Dis. 24, 172 (1994). de Strihou. Kidney Int. 45, 1680 (1994). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1038%2Fki.1994.220%20%2C%20J.-P.%20Cosyns%2C%20M.%20Jadoul%2C%20J.-P.%20Squifflet%2C%20J.-F.%20De%20Plaen%2C%20D.%20Ferluga%2C%20C.%20V.%20Y.%20de%20Strihou.%20Kidney%20Int.%2045%2C%201680%20%281994%29.) 26. P. A. G. M. De Smet, P. A. G. M. De Smet, K. Keller, R. Hansel, R. F. Chandler (Eds.). Adverse Effects of Herbal Drugs, Aristolochia Species, pp. 79-89, Springer Verlag, Berlin (1992). 27. [doi:10.1089/acm.1998.4.1-9](https://doi.org/doi:10.1089/acm.1998.4.1-9), L. J. Vanherwegham. J. Altern. Complement. Med. 4, 9 (1998). [Search Y. de Strihou. Lancet 344, 188 (1994). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2FS0140-6736%2894%2992786-3%20%2C%20J.-P.%20Cosyns%2C%20M.%20Jadoul%2C%20J.-P.%20Squifflet%2C%20P.-J.%20Van%20Cangh%2C%20C.%20V.%20Y.%20de%20Strihou.%20Lancet%20344%2C%20188%20%281994%29.) 29. Therapeutic Goods Administration (TGA) (Australia). Chinese herbal medicines in Australia found to contain Aristolochia <http://www.tga.gov.au/> (2003). [Search in Google Scholar](https://scholar.google.com/scholar?q=Therapeutic%20Goods%20Administration%20%28TGA%29%20%28Australia%29.%20Chinese%20herbal%20medicines%20in%20Australia%20found%20to%20contain%20Aristolochia%20%3Chttp%3A%2F%2Fwww.tga.gov.au%2F%3E%20%282003%29.) 30. ICDRA. International Conference on Drug Regulatory Authorities, World Health Organization (1986). [Search in Google Scholar](https://scholar.google.com/scholar?q=ICDRA.%20International%20Conference%20on%20Drug%20Regulatory%20Authorities%2C%20World%20Health%20Organization%20%281986%29.) 31. ICDRA. 6th International Conference on Drug Regulatory Authorities, World Health Organization (1991). [Search in Google Scholar](https://scholar.google.com/scholar?q=ICDRA.%206th%20International%20Conference%20on%20Drug%20Regulatory%20Authorities%2C%20World%20Health%20Organization%20%281991%29.) 32. ICDRA. 8th International Conference on Drug Regulatory Authorities, World Health Organization, Bahrain, 10-13 Nov. (1996). [Search in Google Scholar](https://scholar.google.com/scholar?q=ICDRA.%208th%20International%20Conference%20on%20Drug%20Regulatory%20Authorities%2C%20World%20Health%20Organization%2C%20Bahrain%2C%2010-13%20Nov.%20%281996%29.) 33. ICDRA. 9th International Conference on Drug Regulatory Authorities, World Health Organization, Berlin, 25-29 April (1999). [Search in Google Scholar](https://scholar.google.com/scholar?q=ICDRA.%209th%20International%20Conference%20on%20Drug%20Regulatory%20Authorities%2C%20World%20Health%20Organization%2C%20Berlin%2C%2025-29%20April%20%281999%29.) 34. G. Shia, B. Noller, G. Burford. \"Safety issues and policies\", in Traditional, Complementary and Alternative Medicine: Policy and Public Health Perspectives, G. Bodeker, G. Burford (Eds.), Chap. 4, pp. 83-98, Imperial College Press, London (2007). [Search in Google Scholar](https://scholar.google.com/scholar?q=G.%20Shia%2C%20B.%20Noller%2C%20G.%20Burford.%20%22Safety%20issues%20and%20policies%22%2C%20in%20Traditional%2C%20Complementary%20and%20Alternative%20Medicine%3A%20Policy%20and%20Public%20Health%20Perspectives%2C%20G.%20Bodeker%2C%20G.%20Burford%20%28Eds.%29%2C%20Chap.%204%2C%20pp.%2083-98%2C%20Imperial%20College%20Press%2C%20London%20%282007%29.) 35. Therapeutic Goods Administration (TGA) (Australia). <http://www.tga.gov.au/cm/cm.htm> (2004). [Search in Google Scholar](https://scholar.google.com/scholar?q=Therapeutic%20Goods%20Administration%20%28TGA%29%20%28Australia%29.%20%3Chttp%3A%2F%2Fwww.tga.gov.au%2Fcm%2Fcm.htm%3E%20%282004%29.) 36. TDR. Operational Guidance: Information Needed to Support Clinical Trials of Herbal Products, UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR) (2005). [Search in Google Scholar](https://scholar.google.com/scholar?q=TDR.%20Operational%20Guidance%3A%20Information%20Needed%20to%20Support%20Clinical%20Trials%20of%20Herbal%20Products%2C%20UNICEF%2FUNDP%2FWorld%20Bank%2FWHO%20Special%20Program%20for%20Research%20and%20Training%20in%20Tropical%20Diseases%20%28TDR%29%20%282005%29.) 37. P. F. Ricci. Environmental and Health Risk Assessment and Management: Principles and Practices, Springer, Dordrecht (2006). [Search in Google Scholar](https://scholar.google.com/scholar?q=P.%20F.%20Ricci.%20Environmental%20and%20Health%20Risk%20Assessment%20and%20Management%3A%20Principles%20and%20Practices%2C%20Springer%2C%20Dordrecht%20%282006%29.) 38. Standards Association of Australia. Risk Management AS/NZS, p. 4360, Strathfield, NSW (1999). [Search in Google Scholar](https://scholar.google.com/scholar?q=Standards%20Association%20of%20Australia.%20Risk%20Management%20AS%2FNZS%2C%20p.%204360%2C%20Strathfield%2C%20NSW%20%281999%29.) 39. M. R. Sim, J. J. McNeil. Med. J. Aust. 170, 372 (1999). [Search in Google Scholar](https://scholar.google.com/scholar?q=M.%20R.%20Sim%2C%20J.%20J.%20McNeil.%20Med.%20J.%20Aust.%20170%2C%20372%20%281999%29.) 40. EnHealth. Environmental Health Risk Assessment: Guidelines for Assessing Human Health Risks from Environmental Hazards, p. 227, Department of Health and Aged Care and enHealth Council, Canberra (2002). [Search in Google Scholar](https://scholar.google.com/scholar?q=EnHealth.%20Environmental%20Health%20Risk%20Assessment%3A%20Guidelines%20for%20Assessing%20Human%20Health%20Risks%20from%20Environmental%20Hazards%2C%20p.%20227%2C%20Department%20of%20Health%20and%20Aged%20Care%20and%20enHealth%20Council%2C%20Canberra%20%282002%29.) 41. USEPA. Guidelines for Ecological Risk Assessment, p. 188, U.S. Environmental Protection Agency, Washington, DC (1998). [Search in Google Scholar](https://scholar.google.com/scholar?q=USEPA.%20Guidelines%20for%20Ecological%20Risk%20Assessment%2C%20p.%20188%2C%20U.S.%20Environmental%20Protection%20Agency%2C%20Washington%2C%20DC%20%281998%29.) 42. Aristotle. Organon, in Masterpieces of World Philosophy, N. Magill (Ed.), p. 137, George Allen & Unwin, London (1963). [Search in Google Scholar](https://scholar.google.com/scholar?q=Aristotle.%20Organon%2C%20in%20Masterpieces%20of%20World%20Philosophy%2C%20N.%20Magill%20%28Ed.%29%2C%20p.%20137%2C%20George%20Allen%20%26%20Unwin%2C%20London%20%281963%29.) 43. C. H. Hennekens, J. E. Buring. \"Design strategies in epidemiologic research\", in Epidemiology in Medicine, S. L. Mayrent (Ed.), p. 16, Lippincott Williams & Wilkins, Philadelphia (1987). [Search in Google Scholar](https://scholar.google.com/scholar?q=C.%20H.%20Hennekens%2C%20J.%20E.%20Buring.%20%22Design%20strategies%20in%20epidemiologic%20research%22%2C%20in%20Epidemiology%20in%20Medicine%2C%20S.%20L.%20Mayrent%20%28Ed.%29%2C%20p.%2016%2C%20Lippincott%20Williams%20%26%20Wilkins%2C%20Philadelphia%20%281987%29.) 44. S. Plantadosis. In Clinical TrialsA Methodologic Perspective, Plantadosis (Ed.), p. 9, Wiley-Interscience, New York (2005). [10.1002/0471740136](https://doi.org/10.1002/0471740136) [Search in Google Scholar](https://scholar.google.com/scholar?q=S.%20Plantadosis.%20In%20Clinical%20TrialsA%20Methodologic%20Perspective%2C%20Plantadosis%20%28Ed.%29%2C%20p.%209%2C%20Wiley-Interscience%2C%20New%20York%20%282005%29.) 45. R. H. Fletcher, S. W. Fletcher. N. Eng. J. Med. 301, 180 (1979). [Search in Google Scholar](https://scholar.google.com/scholar?q=R.%20H.%20Fletcher%2C%20S.%20W.%20Fletcher.%20N.%20Eng.%20J.%20Med.%20301%2C%20180%20%281979%29.) 46. S. Plantadosis. In Clinical TrialsA Methodologic Perspective, Plantadosis (Ed.), p. 82, Wiley-Interscience, New York [10.1002/0471740136](https://doi.org/10.1002/0471740136) [Search in Google Scholar](https://scholar.google.com/scholar?q=S.%20Plantadosis.%20In%20Clinical%20TrialsA%20Methodologic%20Perspective%2C%20Plantadosis%20%28Ed.%29%2C%20p.%2082%2C%20Wiley-Interscience%2C%20New%20York%20%282005%29.) 47. [doi:10.1002/9780470057438.ch2](https://doi.org/doi:10.1002/9780470057438.ch2), M. Pawa. In Complimentary Therapy and the Management of Diabetes and Vascular DiseaseA Matter of Balance, P. T. Dunning (Ed.), p. 17, John Wiley, Chichester (2006). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1002%2F9780470057438.ch2%20%2C%20M.%20Pawa.%20In%20Complimentary%20Therapy%20and%20the%20Management%20of%20Diabetes%20and%20Vascular%20DiseaseA%20Matter%20of%20Balance%2C%20P.%20T.%20Dunning%20%28Ed.%29%2C%20p.%2017%2C%20John%20Wiley%2C%20Chichester%20%282006%29.) 48. O. Akerele. Herbalgram 28, 13 (1993). [10.1353/sais.1993.0034](https://doi.org/10.1353/sais.1993.0034) [Search Google und Klinische 3, Steinkopff (1998). [Search in Google 2, 465 (2005). [Search in Google Scholar](https://scholar.google.com/scholar?q=B.%20Patwardhan%2C%20D.%20Warude%2C%20P.%20Pushpangadan%2C%20N.%20Bhatt.%20Evidence-Based%20Complem.%20Altern.%20Med.%202%2C%20465%20%282005%29.) 51. WHO. Traditional Medicine Strategy 2002-2005. <http://www.who.int/medicines/library/trm/trm_stat_eng.pdfS> (2002). [Search in Google Scholar](https://scholar.google.com/scholar?q=WHO.%20Traditional%20Medicine%20Strategy%202002-2005.%20%3Chttp%3A%2F%2Fwww.who.int%2Fmedicines%2Flibrary%2Ftrm%2Ftrm_stat_eng.pdfS%3E%20%282002%29.) 52. J. 61 (1995). [10.1017/S0012217300049301](https://doi.org/10.1017/S0012217300049301) [Search in Google Scholar](https://scholar.google.com/scholar?q=J.%20Gruenwald.%20Herbalgram%2034%2C%2061%20%281995%29.) 53. [doi:10.1016/S0091-2182(99)00042-7](https://doi.org/doi:10.1016/S0091-2182(99)00042-7), L. Lee. J. Nurse-Midwifery 44, 253 (1999). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2FS0091-2182%2899%2900042-7%20%2C%20L.%20Lee.%20J.%20Nurse-Midwifery%2044%2C%20253%20%281999%29.) 54. [doi:10.1002/nur.4770140505](https://doi.org/doi:10.1002/nur.4770140505), J. S. Brown, S. A. Marcy. Res. Nurs. Health 14, 339 (1991). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1002%2Fnur.4770140505%20%2C%20J.%20S.%20Brown%2C%20S.%20A.%20Marcy.%20Res.%20Nurs.%20Health%2014%2C%20339%20%281991%29.) 55. [doi:10.1016/j.amjmed.2003.10.036](https://doi.org/doi:10.1016/j.amjmed.2003.10.036), S. Bent, R. Ko. Am. J. Med. 116, 478 (2004). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2Fj.amjmed.2003.10.036%20%2C%20S.%20Bent%2C%20R.%20Ko.%20Am.%20J.%20Med.%20116%2C%20478%20%282004%29.) 56. [doi:10.1016/j.lfs.2005.12.019](https://doi.org/doi:10.1016/j.lfs.2005.12.019), I. A. Khan. Life Sci. 78, 2033 (2006). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2Fj.lfs.2005.12.019%20%2C%20I.%20A.%20Khan.%20Life%20Sci.%2078%2C%202033%20%282006%29.) 57. [doi:10.1056/NEJM200006083422301](https://doi.org/doi:10.1056/NEJM200006083422301), J. L. Nortier, M.-C. M. Martinez, H. H. Schmeiser, V. M. Arlt, C. A. Bieler, M. Petein, F. Depierreux, L. De D. Abramowicz, P. Vereerstraeten, J. L. Vanherweghem. N. Engl. J. Medicine 342, 1686 (2000). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1056%2FNEJM200006083422301%20%2C%20J.%20L.%20Nortier%2C%20M.-C.%20M.%20Martinez%2C%20H.%20H.%20Schmeiser%2C%20V.%20M.%20Arlt%2C%20C.%20A.%20Bieler%2C%20M.%20Petein%2C%20F.%20Depierreux%2C%20L.%20De%20Pauw%2C%20D.%20Abramowicz%2C%20P.%20Vereerstraeten%2C%20J.%20L.%20Vanherweghem.%20N.%20Engl.%20J.%20Medicine%20342%2C%201686%20%282000%29.) 58. [doi:10.2165/00002018-200023050-00001](https://doi.org/doi:10.2165/00002018-200023050-00001), H. L. Koh, S. O. Woo. Drug Safety 23, 351 (2000). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.2165%2F00002018-200023050-00001%20%2C%20H.%20L.%20Koh%2C%20S.%20O.%20Woo.%20Drug%20Safety%2023%2C%20351%20%282000%29.) 59. [doi:10.1016/j.lfs.2005.12.014](https://doi.org/doi:10.1016/j.lfs.2005.12.014), V. S. Srinivasan. Life Sci. 78, 2039 (2006). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2Fj.lfs.2005.12.014%20%2C%20V.%20S.%20Srinivasan.%20Life%20Sci.%2078%2C%202039%20%282006%29.) [doi:10.1016/j.phymed.2006.11.011](https://doi.org/doi:10.1016/j.phymed.2006.11.011), Jobst, D. H. Vetter, H. Wagner. Phytomedicine 14, 70 (2007). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2Fj.phymed.2006.11.011%20%2C%20G.%20Ulrich-Merzenich%2C%20H.%20Zeitler%2C%20D.%20Jobst%2C%20D.%20Panek%2C%20H.%20Vetter%2C%20H.%20Wagner.%20Phytomedicine%2014%2C%2070%20%282007%29.) 61. EMEA. Position paper on the risks associated with the use of herbal products containing Aristolochia species. EMEA/HMPWP/23/00 (2000). [Search in Google Scholar](https://scholar.google.com/scholar?q=EMEA.%20Position%20paper%20on%20the%20risks%20associated%20with%20the%20use%20of%20herbal%20products%20containing%20Aristolochia%20species.%20EMEA%2FHMPWP%2F23%2F00%20%282000%29.) 62. [doi:10.1007/s002280000194](https://doi.org/doi:10.1007/s002280000194), E. Ernst. Eur. J. Clin. Pharmacol. 56, 523 (2000). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1007%2Fs002280000194%20%2C%20E.%20Ernst.%20Eur.%20J.%20Clin.%20Pharmacol.%2056%2C%20523%20%282000%29.) 63. [doi:10.1046/j.1365-2796.2002.00999.x](https://doi.org/doi:10.1046/j.1365-2796.2002.00999.x), E. Ernst. J. Int. Med. 252, 107 (2002). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1046%2Fj.1365-2796.2002.00999.x%20%2C%20E.%20Ernst.%20J.%20Int.%20Med.%20252%2C%20107%20%282002%29.) 64. [doi:10.1001/archinte.158.20.2192](https://doi.org/doi:10.1001/archinte.158.20.2192), L. C. Winslow, D. J. Kroll. Arch. Intern. Med. 158, 2192 (1998). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1001%2Farchinte.158.20.2192%20%2C%20L.%20C.%20Winslow%2C%20D.%20J.%20Kroll.%20Arch.%20Intern.%20Med.%20158%2C%202192%20%281998%29.) 65. M. Rotblatt, I. Ziment. Evidence-Based Herbal Medicine, Hanley & Belfus, Philadelphia (2002). [Search in Google Scholar](https://scholar.google.com/scholar?q=M.%20Rotblatt%2C%20I.%20Ziment.%20Evidence-Based%20Herbal%20Medicine%2C%20Hanley%20%26%20Belfus%2C%20Philadelphia%20%282002%29.) 66. M. Blumenthal (Ed.). The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicines, American Botanical Council, Austin, TX (1997). [Search in Google Scholar](https://scholar.google.com/scholar?q=M.%20Blumenthal%20%28Ed.%29.%20The%20Complete%20German%20Commission%20E%20Monographs.%20Therapeutic%20Guide%20to%20Herbal%20Medicines%2C%20American%20Botanical%20Council%2C%20Austin%2C%20TX%20%281997%29.) 67. CDER/USFDA. Guidance for Industry, Botanical Drug Products, draft guidance, Center for Drug Evaluation and Research/U.S. Food and Drug Administration (2000). [Search in Google Scholar](https://scholar.google.com/scholar?q=CDER%2FUSFDA.%20Guidance%20for%20Industry%2C%20Botanical%20Drug%20Products%2C%20draft%20guidance%2C%20Center%20for%20Drug%20Evaluation%20and%20Research%2FU.S.%20Food%20and%20Drug%20Administration%20%282000%29.) 68. EMEA. Guideline on Specifications: Test Procedures and Acceptance Criteria for Herbal Drugs, Herbal Drug Preparations and Herbal Medicinal Products/Traditional Herbal Medicinal Products, European Medicines Agency, London, EMEA/CPMP/QWP/2820/00 Rev. 1 and (EMEA/CVMP/815/00), Rev. 1 (2006). [Search in Google Scholar](https://scholar.google.com/scholar?q=EMEA.%20Guideline%20on%20Specifications%3A%20Test%20Procedures%20and%20Acceptance%20Criteria%20for%20Herbal%20Drugs%2C%20Herbal%20Drug%20Preparations%20and%20Herbal%20Medicinal%20Products%2FTraditional%20Herbal%20Medicinal%20Products%2C%20European%20Medicines%20Agency%2C%20London%2C%20EMEA%2FCPMP%2FQWP%2F2820%2F00%20Rev.%201%20and%20%28EMEA%2FCVMP%2F815%2F00%29%2C%20Rev.%201%20%282006%29.) 69. The 2002 United States Pharmacopoeia National Formulary, 25 NF 19/National Inc. [Search in Google Scholar](https://scholar.google.com/scholar?q=The%202002%20United%20States%20Pharmacopoeia%20and%20National%20Formulary%2C%20USP%2025%20NF%2019%2FNational%20Formulary%2020%2C%20Rockville%2C%20MD%2C%20U.S.%20Pharmacopoeial%20Convention%2C%20Inc.%20%282002%29.) 70. Pharmacopoeia of the People's Republic of China, English ed., The Pharmacopoeia Commission of PRC, Beijing (2000). [Search in Google Scholar](https://scholar.google.com/scholar?q=Pharmacopoeia%20of%20the%20People%27s%20Republic%20of%20China%2C%20English%20ed.%2C%20The%20Pharmacopoeia%20Commission%20of%20PRC%2C%20Beijing%20%282000%29.) 71. [doi:10.1007/s00216-002-1265-3](https://doi.org/doi:10.1007/s00216-002-1265-3), C. W. Huie. (2002). in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1007%2Fs00216-002-1265-3%20%2C%20C.%20W.%20Huie.%20Anal.%20Bioanal.%20Chem.%20373%2C%2023%20%282002%29.) 72. [doi:10.1016/S0165-9936(99)00185-5](https://doi.org/doi:10.1016/S0165-9936(99)00185-5), V. Camel. Trends Anal. Chem. 19, 229 (2000). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2FS0165-9936%2899%2900185-5%20%2C%20V.%20Camel.%20Trends%20Anal.%20Chem.%2019%2C%20229%20%282000%29.) 76. [doi:10.1039/a907244f](https://doi.org/doi:10.1039/a907244f), V. Fernandez-Perez, M. M. Jimenez-Carmona, M. D. L. De Castro. Analyst 125, 481 (2000). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1039%2Fa907244f%20%2C%20V.%20Fernandez-Perez%2C%20M.%20M.%20Jimenez-Carmona%2C%20M.%20D.%20L.%20De%20Castro.%20Analyst%20125%2C%20481%20%282000%29.) 77. [doi:10.1016/S0021-9673(99)00703-7](https://doi.org/doi:10.1016/S0021-9673(99)00703-7), M. M. Jimenez-Carmona, J. L. Ubera, M. D. L. de Castro. J. Chromatogr., A 855, 625 (1999). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2FS0021-9673%2899%2900703-7%20%2C%20M.%20M.%20Jimenez-Carmona%2C%20J.%20L.%20Ubera%2C%20M.%20D.%20L.%20de%20Castro.%20J.%20Chromatogr.%2C%20A%20855%2C%20625%20%281999%29.) 78. [doi:10.1021/jf980437e](https://doi.org/doi:10.1021/jf980437e), A. Basile, M. M. Jimenez-Carmona, A. A. Clifford. J. Agric. Food Chem. 46, 5205 (1998). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1021%2Fjf980437e%20%2C%20A.%20Basile%2C%20M.%20M.%20Jimenez-Carmona%2C%20A.%20A.%20Clifford.%20J.%20Agric.%20Food%20Chem.%2046%2C%205205%20%281998%29.) 79. V. B. Guliyeva, M. Gulb, A. Yildirima. J. Chromatogr., B 812, 291 (2004). [Search in Google Scholar](https://scholar.google.com/scholar?q=V.%20B.%20Guliyeva%2C%20M.%20Gulb%2C%20A.%20Yildirima.%20J.%20Chromatogr.%2C%20B%20812%2C%20291%20%282004%29.) 80. [doi:10.1016/S0928-3420(99)80032-9](https://doi.org/doi:10.1016/S0928-3420(99)80032-9), K. Hostettmann, J. L. \"Rapid determination on plant glycosides by LC/MS and LC/NMR\", in Advances in Plant Glycosides, Chemistry and Biology, C. R. Yang, O. E. Tanaka (Eds.), p. 233, Elsevier, Amsterdam (1999). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2FS0928-3420%2899%2980032-9%20%2C%20K.%20Hostettmann%2C%20J.%20L.%20Wolfender.%20%22Rapid%20determination%20on%20plant%20glycosides%20by%20LC%2FMS%20and%20LC%2FNMR%22%2C%20in%20Advances%20in%20Plant%20Glycosides%2C%20Chemistry%20and%20Biology%2C%20C.%20R.%20Yang%2C%20O.%20E.%20Tanaka%20%28Eds.%29%2C%20p.%20233%2C%20Elsevier%2C%20Amsterdam%20%281999%29.) 81. [doi:10.1016/S0308-8146(97)00103-9](https://doi.org/doi:10.1016/S0308-8146(97)00103-9), P. S. Belton, I. J. Colquhoun, E. K. Kemsley, I. Delgadillo, P. Roma, M. J. Dennis, M. Sharman, E. Holmes, J. K. Nicholson, M. Spraul. Food Chem. 61, 207 (1998). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2FS0308-8146%2897%2900103-9%20%2C%20P.%20S.%20Belton%2C%20I.%20J.%20Colquhoun%2C%20E.%20K.%20Kemsley%2C%20I.%20Delgadillo%2C%20P.%20Roma%2C%20M.%20J.%20Dennis%2C%20M.%20Sharman%2C%20E.%20Holmes%2C%20J.%20K.%20Nicholson%2C%20M.%20Spraul.%20Food%20Chem.%2061%2C%20207%20%281998%29.) 82. [doi:10.1016/j.phytochem.2004.06.015](https://doi.org/doi:10.1016/j.phytochem.2004.06.015), M. Frederich, Y. H. Choi, L. Angenot, G. Harnischfeger, A. W. M. Lefeber, R. Verpoorte. Phytochemistry 65, 1993 (2004). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2Fj.phytochem.2004.06.015%20%2C%20M.%20Frederich%2C%20Y.%20H.%20Choi%2C%20L.%20Angenot%2C%20G.%20Harnischfeger%2C%20A.%20W.%20M.%20Lefeber%2C%20R.%20Verpoorte.%20Phytochemistry%2065%2C%201993%20%282004%29.) 83. [doi:10.1016/j.phytochem.2004.01.019](https://doi.org/doi:10.1016/j.phytochem.2004.01.019), H. K. Choi, Y. H. Choi, M. Verberne, A. W. M. Lefeber, C. Erkelens, R. Verpoorte. Phytochemistry 65, 857 (2004). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2Fj.phytochem.2004.01.019%20%2C%20H.%20K.%20Choi%2C%20Y.%20H.%20Choi%2C%20M.%20Verberne%2C%20A.%20W.%20M.%20Lefeber%2C%20C.%20Erkelens%2C%20R.%20Verpoorte.%20Phytochemistry%2065%2C%20857%20%282004%29.) 84. P. J. Hylands, J. K. Nicholson, E. Holmes, M. J. Dunn. U.S. patent 6806090 (2004). [Search in Google Scholar](https://scholar.google.com/scholar?q=P.%20J.%20Hylands%2C%20J.%20K.%20Nicholson%2C%20E.%20Holmes%2C%20M.%20J.%20Dunn.%20U.S.%20patent%206806090%20%282004%29.) 85. [doi:10.1016/S0929-693X(03)00274-4](https://doi.org/doi:10.1016/S0929-693X(03)00274-4), Moulene, K. Retornaz, N. Prost, L. Dehoro. Arch. Pediatrics 10, 619 (2003). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2FS0929-693X%2803%2900274-4%20%2C%20P.%20Mionodies%2C%20P.%20Pommier%2C%20E.%20Moulene%2C%20K.%20Retornaz%2C%20N.%20Prost%2C%20L.%20Dehoro.%20Arch.%20Pediatrics%2010%2C%20619%20%282003%29.) 86. Anon. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine, p. 4, World Health Organization, Geneva (2000). [Search in Google Scholar](https://scholar.google.com/scholar?q=Anon.%20General%20Guidelines%20for%20Methodologies%20on%20Research%20and%20Evaluation%20of%20Traditional%20Medicine%2C%20p.%204%2C%20World%20Health%20Organization%2C%20Geneva%20%282000%29.) 87. [doi:10.1016/j.jpba.2004.11.044](https://doi.org/doi:10.1016/j.jpba.2004.11.044), A. T. Elamthuruthya, C. R. Shah, T. A. Khan, P. A. Tatke, S. Y. Gabhe. J. Pharm. Biomed Anal. 37, in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2Fj.talanta.2005.10.007%20%2C%20G.%20Biringanine%2C%20M.-T.%20Chirelli%2C%20M.%20Faes%2C%20P.%20Duez.%20Talanta%2069%2C%20418%20%282006%29.) 89. [doi:10.1002/jps.1035](https://doi.org/doi:10.1002/jps.1035), E. A. Abouarshed, I. A. Khan. J. Pharm. Sci. 90, 817 (2001). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1002%2Fjps.1035%20%2C%20E.%20A.%20Abouarshed%2C%20I.%20A.%20Khan.%20J.%20Pharm.%20Sci.%2090%2C%20817%20%282001%29.) 90. H. Elsohly, E. M. Croom, M. A. Elsohly. Pharm. Res. 4, 258 (1987). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1023%2FA%3A1016472531527%20%2C%20H.%20Elsohly%2C%20E.%20M.%20Croom%2C%20M.%20A.%20Elsohly.%20Pharm.%20Res.%204%2C%20258%20%281987%29.) 91. [doi:10.1002/jps.1124](https://doi.org/doi:10.1002/jps.1124), H. Ganzora, E. Bedin, I. A. Khan. J. Pharm. Sci. 90, 1752 (2001). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1002%2Fjps.1124%20%2C%20H.%20Ganzora%2C%20E.%20Bedin%2C%20I.%20A.%20Khan.%20J.%20Pharm.%20Sci.%2090%2C%201752%20%282001%29.) 92. M. Ganzora, I. A. Khan. Planta Med. 67, 778 (2001). [Search in Google Scholar](https://scholar.google.com/scholar?q=M.%20Ganzora%2C%20I.%20A.%20Khan.%20Planta%20Med.%2067%2C%20778%20%282001%29.) 93. [doi:10.1021/jf020049j](https://doi.org/doi:10.1021/jf020049j), R. B. Anna, C. B. Maria, L. Diamanto, F. V. Franco. J. Agric. Food Chem. 50, 5016 (2002). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1021%2Fjf020049j%20%2C%20R.%20B.%20Anna%2C%20C.%20B.%20Maria%2C%20L.%20Diamanto%2C%20F.%20V.%20Franco.%20J.%20Agric.%20Food%20Chem.%2050%2C%205016%20%282002%29.) 94. G. M. Hanna. 11th Annual FDA Science Forum, Board Number: I-14, April 27 (2005). [Search in Google Scholar](https://scholar.google.com/scholar?q=G.%20M.%20Hanna.%2011th%20Annual%20FDA%20Science%20Forum%2C%20Board%20Number%3A%20I-14%2C%20April%2027%20%282005%29.) 95. L. Wang, F. S. C. Lee, X. Wang. LWT-Food Sci. Technol. 40, 83 (2007). [Search in Google Scholar](https://scholar.google.com/scholar?q=L.%20Wang%2C%20F.%20S.%20C.%20Lee%2C%20X.%20Wang.%20LWT-Food%20Sci.%20Technol.%2040%2C%2083%20%282007%29.) 96. Romanian Pharmacopoeia X, Chap. IX, Ed, Medicala, Bucuresti (1993). [Search in Google Scholar](https://scholar.google.com/scholar?q=Romanian%20Pharmacopoeia%20X%2C%20Chap.%20IX%2C%20Ed%2C%20Medicala%2C%20Bucuresti%20%281993%29.) 97. British Pharmacopoeia, Vol. IV, Appendix XVI B, A356-A363 (2005). [Search in Google Scholar](https://scholar.google.com/scholar?q=British%20Pharmacopoeia%2C%20Vol.%20IV%2C%20Appendix%20XVI%20B%2C%20A356-A363%20%282005%29.) 98. [doi:10.1111/j.1365-2621.2006.01237.x](https://doi.org/doi:10.1111/j.1365-2621.2006.01237.x), A. Ozbey, U. Uygun. Int. J. Food Sci. Technol. 42, 380 (2007). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1111%2Fj.1365-2621.2006.01237.x%20%2C%20A.%20Ozbey%2C%20U.%20Uygun.%20Int.%20J.%20Food%20Sci.%20Technol.%2042%2C%20380%20%282007%29.) 99. R. O. B. Wijesekera (Ed.). The Medicinal Plant Industry, CRC Press, Boca Raton (1991). [Search in Google Scholar](https://scholar.google.com/scholar?q=R.%20O.%20B.%20Wijesekera%20%28Ed.%29.%20The%20Medicinal%20Plant%20Industry%2C%20CRC%20Press%2C%20Boca%20Raton%20%281991%29.) 100. [doi:10.1007/s00128-007-9063-4](https://doi.org/doi:10.1007/s00128-007-9063-4), V. Rai, P. Kakkar, Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1007%2Fs00128-007-9063-4%20%2C%20V.%20Rai%2C%20P.%20Kakkar%2C%20C.%20Misra%2C%20S.%20K.%20Ojha%2C%20N.%20Srivastava%2C%20S.%20Mehrotra.%20Environ.%20Contam.%20Toxicol.%2079%2C%20269%20%282007%29.) 101. H. Wagner. In Handbook of Medicinal Plants, Z. Yaniv, U. E. Bachrach (Eds.), p. 3, Chap. 21, Haworth Medical Press, Binghamton (2001). [Search in Google Scholar](https://scholar.google.com/scholar?q=H.%20Wagner.%20In%20Handbook%20of%20Medicinal%20Plants%2C%20Z.%20Yaniv%2C%20U.%20E.%20Bachrach%20%28Eds.%29%2C%20p.%203%2C%20Chap.%2021%2C%20Haworth%20Medical%20Press%2C%20Binghamton%20%282001%29.) 102. [doi:10.1590/S0103-50532003000200019](https://doi.org/doi:10.1590/S0103-50532003000200019), V. G. Zuin, J. H. Yariwake, F. M. Lancas. J. Braz. Chem. Soc. 14, 304 (2003). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1590%2FS0103-50532003000200019%20%2C%20V.%20G.%20Zuin%2C%20J.%20H.%20Yariwake%2C%20F.%20M.%20Lancas.%20J.%20Braz.%20Chem.%20Soc.%2014%2C%20304%20%282003%29.) 103. V. G. Zuin, A L. Lopes, J. H. Yarawake, F. Augusto. J. A 233 [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2Fj.talanta.2005.03.023%20%2C%20S.%20Razic%2C%20A.%20Onjia%2C%20S.%20Dogo%2C%20L.%20Slavkovic%2C%20A.%20Popovic.%20Talanta%2067%2C%20233%20%282005%29.) 105. [doi:10.1016/j.microc.2006.05.008](https://doi.org/doi:10.1016/j.microc.2006.05.008), S. Razic, S. M. Dogo, L. J. Slavkovic. Microchem. J. 84, 93 (2006). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2Fj.microc.2006.05.008%20%2C%20S.%20S.%20Razic%2C%20S.%20M.%20Dogo%2C%20L.%20J.%20Slavkovic.%20Microchem.%20J.%2084%2C%2093%20%282006%29.) 106. [doi:10.2298/JSC0610095R](https://doi.org/doi:10.2298/JSC0610095R), S. Razic, S. Dogo, L. Slavkovic. J. Serb. Chem. Soc. 71, 1095 (2006). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.2298%2FJSC0610095R%20%2C%20S.%20Razic%2C%20S.%20Dogo%2C%20L.%20Slavkovic.%20J.%20Serb.%20Chem.%20Soc.%2071%2C%201095%20%282006%29.) 107. [doi:10.1016/S0021-9150(98)00094-X](https://doi.org/doi:10.1016/S0021-9150(98)00094-X), V. M. Dirsch, A. K. Kiemer, H. Wagner, A. M. Vollmar. Atherosclerosis 139, 333 (1998). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2FS0021-9150%2898%2900094-X%20%2C%20V.%20M.%20Dirsch%2C%20A.%20K.%20Kiemer%2C%20H.%20Wagner%2C%20A.%20M.%20Vollmar.%20Atherosclerosis%20139%2C%20333%20%281998%29.) 108. V. M. Dirsch, A. L. A. M. Mol. Pharmacol. in Google Scholar](https://scholar.google.com/scholar?q=S.%20Klingelhofer.%20Isolierung%20und%20Charakterisierung%20antiinflammatorischer%20Oxylipine%20aus%20Blattextrakten%20von%20Urtica%20dioica%20L.%2C%20Ph.D.%20Thesis%2C%20Kiel%2C%20Germany%2C%20Christian-Albrechts-Universitat%2C%20pp.%201-3%20and%2080%20%282001%29.) 110. [doi:10.1016/j.phymed.2004.02.003](https://doi.org/doi:10.1016/j.phymed.2004.02.003), M. Kaszkin, K. F. Beck, E. Koch, C. Erdelmeier, S. Kusch, J. Pfeilschifter, D. Loew. Phytomedicine 11, 585 (2004). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2Fj.phymed.2004.02.003%20%2C%20M.%20Kaszkin%2C%20K.%20F.%20Beck%2C%20E.%20Koch%2C%20C.%20Erdelmeier%2C%20S.%20Kusch%2C%20J.%20Pfeilschifter%2C%20D.%20Loew.%20Phytomedicine%2011%2C%20585%20%282004%29.) 111. W. E Mueller. St. John's Wort and its Active Principles in Depression and Anxiety, Birkhauser, Basel (2005). [10.1007/b137619](https://doi.org/10.1007/b137619) [Search in Google Scholar](https://scholar.google.com/scholar?q=W.%20E%20Mueller.%20St.%20John%27s%20Wort%20and%20its%20Active%20Principles%20in%20Depression%20and%20Anxiety%2C%20Birkhauser%2C%20Basel%20%282005%29.) 112. [doi:10.1016/j.jep.2005.05.033](https://doi.org/doi:10.1016/j.jep.2005.05.033), R. Verpoorte, Y. H. Choi, H. K. Kim. J. Ethnopharmacol. 100, 53 (2005). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2Fj.jep.2005.05.033%20%2C%20R.%20Verpoorte%2C%20Y.%20H.%20Choi%2C%20H.%20K.%20Kim.%20J.%20Ethnopharmacol.%20100%2C%2053%20%282005%29.) 113. [doi:10.1078/0944-7113-00060](https://doi.org/doi:10.1078/0944-7113-00060), E. M. Williamson. Phytomedicine 8, 401 (2001). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1078%2F0944-7113-00060%20%2C%20E.%20M.%20Williamson.%20Phytomedicine%208%2C%20401%20%282001%29.) 114. API (Ayurvedic Pharmacopoeia of India). Department of Health, Ministry of Health and Family Welfare, Government of India, New Delhi, p. 45 (1989). [Search in Google Scholar](https://scholar.google.com/scholar?q=API%20%28Ayurvedic%20Pharmacopoeia%20of%20India%29.%20Department%20of%20Health%2C%20Ministry%20of%20Health%20and%20Family%20Welfare%2C%20Government%20of%20India%2C%20New%20Delhi%2C%20p.%2045%20%281989%29.) 115. P. P. H. But, T. Kimura, J.-X. Guo, C. K. Sung, B. H. Han (Eds.). International Collation of Traditional and Folk Medicine, p. 232, World Scientific, Singapore (1997). [Search in Google Scholar](https://scholar.google.com/scholar?q=P.%20P.%20H.%20But%2C%20T.%20Kimura%2C%20J.-X.%20Guo%2C%20C.%20K.%20Sung%2C%20B.%20H.%20Han%20%28Eds.%29.%20International%20Collation%20of%20Traditional%20and%20Folk%20Medicine%2C%20p.%20232%2C%20World%20Scientific%2C%20Singapore%20%281997%29.) 116. H. M. Chang, P. P. H. But (Eds.). Pharmacology and Applications of Chinese Materia Medica, Vols. I and II, S.-C. Yao, L.-L. Wang, S. C.-S. Yeung (Translators), World Scientific, Philadelphia (2001). [Search in Google Scholar](https://scholar.google.com/scholar?q=H.%20M.%20Chang%2C%20P.%20P.%20H.%20But%20%28Eds.%29.%20Pharmacology%20and%20Applications%20of%20Chinese%20Materia%20Medica%2C%20Vols.%20I%20and%20II%2C%20S.-C.%20Yao%2C%20L.-L.%20Wang%2C%20S.%20C.-S.%20Yeung%20%28Translators%29%2C%20World%20Scientific%2C%20Philadelphia%20%282001%29.) 117. V. K. Gupta. Traditional Knowledge Digital Library, Sub-Regional Experts Meeting in Asia on Intangible Cultural Heritage: Safeguarding and Inventory-Making Methodologies, Bangkok (2005). <http://www.accu.or.jp/ich/en/pdf/c2005subreg_ Ind1.pdf>. [Search in Google Scholar](https://scholar.google.com/scholar?q=V.%20K.%20Gupta.%20Traditional%20Knowledge%20Digital%20Library%2C%20Sub-Regional%20Experts%20Meeting%20in%20Asia%20on%20Intangible%20Cultural%20Heritage%3A%20Safeguarding%20and%20Inventory-Making%20Methodologies%2C%20Bangkok%20%282005%29.%20%3Chttp%3A%2F%2Fwww.accu.or.jp%2Fich%2Fen%2Fpdf%2Fc2005subreg_%20Ind1.pdf%3E.) 118. JSHM. Japanese Standards Herbal Medicines, p. 361, Yakuji Nippo, Tokyo (1993). [Search in Google Scholar](https://scholar.google.com/scholar?q=JSHM.%20Japanese%20Standards%20for%20Herbal%20Medicines%2C%20p.%20361%2C%20Yakuji%20Nippo%2C%20Tokyo%20%281993%29.) 119. Jiangsu Institute of Modern Medicine. Zhong Yao Da Ci Dian (Encyclopedia of Chinese Materia Medica), Vols. 1-3, p. 3518, Shanghai Scientific and Technical Publications, Shanghai (1977). [Search in Google Scholar](https://scholar.google.com/scholar?q=Jiangsu%20Institute%20of%20Modern%20Medicine.%20Zhong%20Yao%20Da%20Ci%20Dian%20%28Encyclopedia%20of%20Chinese%20Materia%20Medica%29%2C%20Vols.%201-3%2C%20p.%203518%2C%20Shanghai%20Scientific%20and%20Technical%20Publications%2C%20Shanghai%20%281977%29.) 120. L. D. Kapoor. CRC Handbook of Ayurvedic Medicinal Plants, Herbal Reference Library, p. 416, CRC Press, Boca Raton (2001). [Search in Google Scholar](https://scholar.google.com/scholar?q=L.%20D.%20Kapoor.%20CRC%20Handbook%20of%20Ayurvedic%20Medicinal%20Plants%2C%20Herbal%20Reference%20Library%2C%20p.%20416%2C%20CRC%20Press%2C%20Boca%20Raton%20%282001%29.) 121. K. M. Nadkarni. Indian Materia Medica, p. 414, Popular Prakashan, Bombay (1976). [Search in Google Scholar](https://scholar.google.com/scholar?q=K.%20M.%20Nadkarni.%20Indian%20Materia%20Medica%2C%20p.%20414%2C%20Popular%20Prakashan%2C%20Bombay%20%281976%29.) 122. T. C. Lantz. Examining the Potential Role of Co-operatives in the Ethical Commercialisation of Medicinal Plants, Plant Conservation Intellectual Property Rights, Ethics, and the Devil's Club (Oplopanax Horridus). Occasional Papers 3, BC Institute for Co-operative Studies, University of Victoria, Victoria, B.C., Canada, 27 (2001). [Search in Google Scholar](https://scholar.google.com/scholar?q=T.%20C.%20Lantz.%20Examining%20the%20Potential%20Role%20of%20Co-operatives%20in%20the%20Ethical%20Commercialisation%20of%20Medicinal%20Plants%2C%20Plant%20Conservation%20Intellectual%20Property%20Rights%2C%20Ethics%2C%20and%20the%20Devil%27s%20Club%20%28Oplopanax%20Horridus%29.%20Occasional%20Papers%203%2C%20BC%20Institute%20for%20Co-operative%20Studies%2C%20University%20of%20Victoria%2C%20Victoria%2C%20B.C.%2C%20Canada%2C%2027%20%282001%29.) 123. G. Tu (Ed.). Pharmacopoeia of the People's Republic of China (English ed., 1992), p. 202, Guangdong Science and Technology Press, Beijing (1992). [Search in Google Scholar](https://scholar.google.com/scholar?q=G.%20Tu%20%28Ed.%29.%20Pharmacopoeia%20of%20the%20People%27s%20Republic%20of%20China%20%28English%20ed.%2C%201992%29%2C%20p.%20202%2C%20Guangdong%20Science%20and%20Technology%20Press%2C%20Beijing%20%281992%29.) 124. United Nations. Convention on Biological Diversity, United Nations Treaty Series UN, New York, Vol. 1760, I-30619, 143 (1993). [Search in Google Scholar](https://scholar.google.com/scholar?q=United%20Nations.%20Convention%20on%20Biological%20Diversity%2C%20United%20Nations%20Treaty%20Series%20UN%2C%20New%20York%2C%20Vol.%201760%2C%20I-30619%2C%20143%20%281993%29.) 125. Online Archive of American Folk Medicine, University of California, Los Angeles. <http://www.folkmed.ucla.edu/>. [Search in Google Scholar](https://scholar.google.com/scholar?q=Online%20Archive%20of%20American%20Folk%20Medicine%2C%20University%20of%20California%2C%20Los%20Angeles.%20%3Chttp%3A%2F%2Fwww.folkmed.ucla.edu%2F%3E.) 126. Phytotherapies database. <http://www.phytotherapies.org/>. [Search Google Scholar](https://scholar.google.com/scholar?q=Phytotherapies%20database.%20%3Chttp%3A%2F%2Fwww.phytotherapies.org%2F%3E.) 127. Natural Medicines [Search in Google [doi:10.1016/S0895-4356(03)00003-9](https://doi.org/doi:10.1016/S0895-4356(03)00003-9), H. P. Knipschild. Clin. Epidem. 56, 367 (2003). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1016%2FS0895-4356%2803%2900003-9%20%2C%20M.%20Van%20Dongen%2C%20E.%20Van%20Rossum%2C%20A.%20Kessels%2C%20H.%20Sielhorst.%20P.%20Knipschild.%20J.%20Clin.%20Epidem.%2056%2C%20367%20%282003%29.) 131. AGRICOLA database, U.S. Department of Agriculture. <http://agricola.nal.usda.gov>. [Search in Google Scholar](https://scholar.google.com/scholar?q=AGRICOLA%20database%2C%20U.S.%20Department%20of%20Agriculture.%20%3Chttp%3A%2F%2Fagricola.nal.usda.gov%3E.) 132. AltHealth Watch database. <http://www.micromedex.com/products/altmeddex/>. [Search in Google Scholar](https://scholar.google.com/scholar?q=MICROMEDEX%20database.%20%3Chttp%3A%2F%2Fwww.micromedex.com%2Fproducts%2Faltmeddex%2F%3E.) 135. Computer Retrieval of Information on Scientific Projects. <http://crisp.cit.nih.gov/>. [Search in Google Scholar](https://scholar.google.com/scholar?q=Computer%20Retrieval%20of%20Information%20on%20Scientific%20Projects.%20%3Chttp%3A%2F%2Fcrisp.cit.nih.gov%2F%3E.) 136. Cochrane [Search in Google Scholar](https://scholar.google.com/scholar?q=EMBASE%2C%20Elsevier.%20%3Chttp%3A%2F%2Fwww.embase.com%2F%3E.) 138. NAPRALERT, College of Pharmacy, University of Illinois at Chicago. <http://napralert.org/>. [Search in Google Scholar](https://scholar.google.com/scholar?q=NAPRALERT%2C%20College%20of%20Pharmacy%2C%20University%20of%20Illinois%20at%20Chicago.%20%3Chttp%3A%2F%2Fnapralert.org%2F%3E.) 139. International Bibliographic Information on Dietary Supplements (IBIDS) database. <http://ods.od.nih.gov/Health_Information/IBIDS.aspx>. [Search in Google Scholar](https://scholar.google.com/scholar?q=International%20Bibliographic%20Information%20on%20Dietary%20Supplements%20%28IBIDS%29%20database.%20%3Chttp%3A%2F%2Fods.od.nih.gov%2FHealth_Information%2FIBIDS.aspx%3E.) 140. European Scientific on (ESCOP) database. <http://www.escop.com/phytonet.htm>. [Search in Google Scholar](https://scholar.google.com/scholar?q=European%20Scientific%20Co-operative%20on%20Phytotherapy%20%28ESCOP%29%20database.%20%3Chttp%3A%2F%2Fwww.escop.com%2Fphytonet.htm%3E.) 141. [doi:10.1007/s002280050674](https://doi.org/doi:10.1007/s002280050674), B. K. Vogler, M. H. Pittler, E. Ernst. Eur. J. Clin. Pharmacol. 55, 567 (1999). [Search in Google Scholar](https://scholar.google.com/scholar?q=doi%3A10.1007%2Fs002280050674%20%2C%20B.%20K.%20Vogler%2C%20M.%20H.%20Pittler%2C%20E.%20Ernst.%20Eur.%20J.%20Clin.%20Pharmacol.%2055%2C%20567%20%281999%29.) 142. S. I. Hakky. U.S. Patent 4826684 (1989). <http://www.freepatentsonline.com/4826684.html>. [Search in Google Scholar](https://scholar.google.com/scholar?q=S.%20I.%20Hakky.%20U.S.%20Patent%204826684%20%281989%29.%20%3Chttp%3A%2F%2Fwww.freepatentsonline.com%2F4826684.html%3E.) 143. S. Y. Lee. U.S. Patent 6692777 (2004). <http://www.patentstorm.us/patents/6692777.html>. [Search in Google Scholar](https://scholar.google.com/scholar?q=S.%20Y.%20Lee.%20U.S.%20Patent%206692777%20%282004%29.%20%3Chttp%3A%2F%2Fwww.patentstorm.us%2Fpatents%2F6692777.html%3E.) 144. R. Glaser. U.S. Patent 20070059384 (2007). <http://www.freepatentsonline.com/20070059384.html>. [Search in Google Scholar](https://scholar.google.com/scholar?q=R.%20Glaser.%20U.S.%20Patent%2020070059384%20%282007%29.%20%3Chttp%3A%2F%2Fwww.freepatentsonline.com%2F20070059384.html%3E.) 145. WHO. WHO Monographs of Selected Medicinal Plants, Vol. 1, p. 289, World Health Organization, Geneva, Switzerland (1999). [Search in Google Scholar](https://scholar.google.com/scholar?q=WHO.%20WHO%20Monographs%20of%20Selected%20Medicinal%20Plants%2C%20Vol.%201%2C%20p.%20289%2C%20World%20Health%20Organization%2C%20Geneva%2C%20Switzerland%20%281999%29.) 146. WHO. WHO Monographs of Selected Medicinal Plants, Vol. 2, p. 351, World Health Organization, Geneva, Switzerland (2002). [Search in Google Scholar](https://scholar.google.com/scholar?q=WHO.%20WHO%20Monographs%20of%20Selected%20Medicinal%20Plants%2C%20Vol.%202%2C%20p.%20351%2C%20World%20Health%20Organization%2C%20Geneva%2C%20Switzerland%20%282002%29.) "}